Last reviewed · How we verify
NCT04475068
Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection
trial testing Lateral Position (left and right lateral decubitus) in Sars-CoV2 in 15 participants. Completed in 31 October 2020.
30 September 2020
Quick facts
| Lead sponsor | Hospital Nacional Edgardo Rebagliati Martins |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 17 July 2020 |
| Primary completion | 30 September 2020 |
| Estimated completion | 31 October 2020 |
| Sites | 1 location across Peru |
Drugs / interventions tested
- Lateral Position (left and right lateral decubitus)
Conditions studied
Sponsor
Hospital Nacional Edgardo Rebagliati Martins
Who can join
18 and older, any sex, with Sars-CoV2 or ARDS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate if a postural recruitment maneuver (PRM) improves the aeration and distribution of lung ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection; without the need to reach high airway pressures as in the standard lung recruitment maneuver and / or place the patient in prone position. This strategy could be particularly useful in the context of a major health emergency in centers with limited resources.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sequential lateral positioning as a new lung recruitment maneuver: an exploratory study in early mechanically ventilated Covid-19 ARDS patients.
Roldán R, Rodriguez S, Barriga F, Tucci M, et al · · 2022 · cited 30× · PMID 35150355 · DOI 10.1186/s13613-022-00988-9
Verify or expand the search:
- PubMed search for NCT04475068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sars-CoV2
Currently open trials in the same condition.
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04363853 — Tocilizumab Treatment in Patients With COVID-19 · Phase 2 · active not recruiting
- NCT04424992 — The Natural History of Hospitalized COVID-19 Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04475068 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Nacional Edgardo Rebagliati Martins
- Last refreshed: 25 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04475068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing